Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 5Phase NA 2Phase 1/2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma 6Colorectal Neoplasms 6Stomach Neoplasms 5Rectal Neoplasms 5Colonic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Osteosarcoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2HIV Infections 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Acquired Immunodeficiency Syndrome 2Sezary Syndrome 1Peritoneal Neoplasms 1Neoplastic Cells, Circulating 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Hydatidiform Mole, Invasive 1Gestational Trophoblastic Disease 1Gastrointestinal Neoplasms 1Choriocarcinoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Appendiceal Neoplasms 1

Interventions

Methotrexate 3Ifosfamide 3Cisplatin 3Magnetic Resonance Spectroscopy 2Leucovorin 2Electroacupuncture 2Doxorubicin 2sargramostim 1regorafenib 1delta 24-sterol reductase 1apatinib 1Tissue and Organ Procurement 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Resistance Training 1Radiotherapy, Image-Guided 1Proton Therapy 1Positron Emission Tomography Computed Tomography 1Physical Therapy Modalities 1Pentetic Acid 1Palliative Care 1Nutritional Support 1Neuropsychological Tests 1Neoadjuvant Therapy 1Minocycline 1Mesna 1Heparin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Glutamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Osteosarcoma × Leucovorin × Clear all
NCT01758666 2015-12-22

A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
40 enrolled
Sarcoma

Osteosarcoma

NCT00673179 2014-09-10

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

M.D. Anderson Cancer Center

Phase NA Terminated
7 enrolled 3 charts
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡